Larixol
Based on 1 Customer Validation
Larixol is an fMLP inhibitor and also inhibits Src kinase, ERK1/2, p38 and AKT phosphorylation signals in immune regulation. Larixol can interfere with the interaction between the βγ subunit of the fMLP receptor Gi protein and its downstream molecules, thereby inhibiting fMLP-induced respiratory burst. Larixol inhibits fMLP (0.1 μM)-induced superoxide anion production (IC50: 1.98 μM), cathepsin G release (IC50: 2.76 μM), and chemotaxis. Larixol improves neutrophil hyperactivation and reduces inflammation or tissue damage. A series of Larixol derivatives were found to have inhibitory effects on FSGS-related TRPC6 functional mutants.
For research use only. We do not sell to patients.
- Purity: 95.52%
- CAS No.: 1438-66-0
- Formula: C20H34O2
- Molecular Weight:306.48
-
Storage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
(+)-Larixol[1]
Chemical Information
-
CAS No. 1438-66-0
-
Appearance Solid
-
Molecular Weight 306.48
-
Formula C20H34O2
-
Color White to off-white
-
SMILES
C[C@]12[C@@](C(C)(CCC2)C)([H])[C@H](CC([C@@H]1CC[C@](C)(O)C=C)=C)O
-
Synonyms
(+)-Larixol
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
DMSO : 50 mg/mL (163.14 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (273 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Liao HR, et al. Larixol inhibits fMLP-induced superoxide anion production and chemotaxis by targeting the βγ subunit of Gi-protein of fMLP receptor in human neutrophils. Biochem Pharmacol. 2022 Jul;201:115091. [Content Brief]
[2]. Urban N, et al. Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol. Br J Pharmacol. 2017 Nov;174(22):4099-4122. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.2629 mL | 16.3143 mL | 32.6286 mL | 81.5714 mL |
| 5 mM | 0.6526 mL | 3.2629 mL | 6.5257 mL | 16.3143 mL | |
| 10 mM | 0.3263 mL | 1.6314 mL | 3.2629 mL | 8.1571 mL | |
| 15 mM | 0.2175 mL | 1.0876 mL | 2.1752 mL | 5.4381 mL | |
| 20 mM | 0.1631 mL | 0.8157 mL | 1.6314 mL | 4.0786 mL | |
| 25 mM | 0.1305 mL | 0.6526 mL | 1.3051 mL | 3.2629 mL | |
| 30 mM | 0.1088 mL | 0.5438 mL | 1.0876 mL | 2.7190 mL | |
| 40 mM | 0.0816 mL | 0.4079 mL | 0.8157 mL | 2.0393 mL | |
| 50 mM | 0.0653 mL | 0.3263 mL | 0.6526 mL | 1.6314 mL | |
| 60 mM | 0.0544 mL | 0.2719 mL | 0.5438 mL | 1.3595 mL | |
| 80 mM | 0.0408 mL | 0.2039 mL | 0.4079 mL | 1.0196 mL | |
| 100 mM | 0.0326 mL | 0.1631 mL | 0.3263 mL | 0.8157 mL |
Larixol Related Classifications
HY-W744699 Related Classifications
Powered by Bioz